Horizon Therapeutics
Horizon Pharma Public Limited Company · public limited company
Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 76 % · cci-v1
14 active sensors·3 observations·0 historical changes·0 structured events·historical coverage 67 %·observed since 2026-09-13
Compare Horizon Therapeutics with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
